Ten new companies enter BioInnovation Institute's Venture Lab program

Bobby Soni, Chief Business Officer at BioInnovation Institute, said:"We are pleased to welcome this new cohort of early-stage companies working across the bioindustrials, therapeutics, women's health and health tech industries to the Venture Lab program. BII's mission is to create products for the welfare of people and society, and we believe that BII's support of the innovative science in this Venture Lab cohort will deliver on that promise." Bobby Soni, Chief Business Officer at...
Comunicato Precedente

next
Comunicato Successivo

next
COPENHAGEN, Denmark, (informazione.it - comunicati stampa - varie)

Bobby Soni, Chief Business Officer at BioInnovation Institute, said:"We are pleased to welcome this new cohort of early-stage companies working across the bioindustrials, therapeutics, women's health and health tech industries to the Venture Lab program. BII's mission is to create products for the welfare of people and society, and we believe that BII's support of the innovative science in this Venture Lab cohort will deliver on that promise."

Each start-up will be supported in undertaking the necessary steps to reach initial proof-of-concept, to make a business plan and to set up a team. Assisted by a dedicated scientific advisor, a leadership coach and a BII business development expert, the new ventures will be guided in developing a detailed milestone plan and will be assisted in overcoming the challenges of growing a business allowing them to progress rapidly towards the market.

The new companies BII has accepted into the Venture Lab acceleration program are:

Since its inception in 2018, BII has supported 80 start-ups and projects with EUR 65 million alongside the venture capital, industry and business expertise it provides to help them accelerate to the next level.  In total, BII's start-ups have raised over EUR 333 million in external funding from both local and international investors.  Recent company successes include Adcendo, Stipe Therapeutics, Twelve Bio, Octarine Bio, and Cirqle Biomedical.

Read more about the Venture Lab program 

About the BioInnovation Institute Foundation:

At BioInnovation Institute (BII), we accelerate world-class life science start-up innovation for the benefit of people and society. As a non-profit institute, BII operates the company creation programs, Bio Studio, Venture Lab and Venture House, to support life science start-ups with knowledge, network, infrastructure and funding of up to 3M EUR per projects and 1,8 M EUR per start-up. With our expertise, network, funding, and infrastructure, we empower startups to succeed and believe in the transformative power of life science innovation. Read more on www.bioinnovationinstitute.com 

Cision View original content:https://www.prnewswire.co.uk/news-releases/ten-new-companies-enter-bioinnovation-institutes-venture-lab-program-301758581.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Slide ShowSlide Show
Non disponibili